Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T07:26:43.126Z Has data issue: false hasContentIssue false
  • English
  • Français

The involvement of oestrogen in the development and progression of breast disease: epidemiological evidence

Published online by Cambridge University Press:  05 December 2011

M. P. Vessey
M. P. Vessey
Affiliation:
Department of Community Medicine & General Practice, Radcliffe Infirmary, Oxford, OX2 6HE, U.K.
Get access

Synopsis

The epidemiological approach to the investigation of breast cancer is briefly described with special reference to case-control and cohort studies. Risk factors for breast cancer are then reviewed, paying particular attention to menstrual and reproductive factors and to body weight. Some of the hypotheses which attempt to draw the epidemiological observations together are also outlined.

The effects of exposure to exogenous oestrogens are considered in more detail. There is evidence from one study that the administration of large doses of stilboestrol during pregnancy increases breast cancer risk after a latent interval of about twenty years. Conjugated equine oestrogens administered to postmenopausal women may also slightly increase breast cancer risk after prolonged use. Little information is available about the effects of any other type of “hormone replacement therapy”. Combined oral contraceptives do not appear to have any general effect on breast cancer risk, but prolonged early use, especially use before first term pregnancy, may be harmful to the breast.

Type
Research Article
Information
Proceedings of the Royal Society of Edinburgh, Section B: Biological Sciences , Volume 95: Oestrogen and the Human Breast , 1989 , pp. 35 - 48
Copyright
Copyright © Royal Society of Edinburgh 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, T. J., Ferguson, D. J. P. & Raab, G. M. 1982. Cell turnover in the “resting” human breast: influence of parity, contraceptive pill, age and laterality. British Journal of Cancer 46, 376–382.CrossRefGoogle ScholarPubMed
Beral, V. & Colwell, L. 1980. Randomised trial of high doses of stilboestrol and ethisterone in pregnancy. Long-term follow-up of mothers. British Medical Journal ii, 1098–1101.CrossRefGoogle Scholar
Bibbo, M., Haenszel, W. M., Wied, G. L., Hubby, M. & Herbst, A. L. 1978. A twenty-five year follow-up study of women exposed to diethylstilboestrol during pregnancy. New England Journal of Medicine 298, 763–767.Google Scholar
Brackbill, Y. & Berendes, H. W. 1978. Dangers of diethylstilboestrol: a review of a 1953 paper. Lancet ii, 520.CrossRefGoogle Scholar
Brian, D. D., Tilley, B. C., Labarthe, D. R., O'Fallon, W. M., Noller, K. L. & Kurland, L. T. 1980. Breast cancer in DES-exposed mothers. Absence of association. Mayo Clinic Proceedings 55, 89–93.Google ScholarPubMed
Brinton, L. A., Hoover, R. & Fraumeni, J. F. 1986. Menopausal oestrogens and breast cancer risk: An expanded case-control study. British Journal of Cancer 54, 825–832.Google Scholar
Bulbrook, R. D., Leake, R. E. & George, W. D. 1989. Oestrogens in the initiation and promotion of breast cancer. Proceedings of the Royal Society of Edinburgh 95B, 67–76.Google Scholar
Buring, J. E., Hennekens, C. H., Lipnick, R. J., Willett, W., Stampfer, M. J., Rosner, B., Peto, R. & Speizer, F. E. 1987. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. American Journal of Epidemiology 125, 939–947.CrossRefGoogle ScholarPubMed
DeWaard, F. & Trichopoulos, D. 1988. A unifying concept of the aetiology of breast cancer. International Journal of Cancer 41, 666–669.Google Scholar
Dieckmann, W. J., Davis, M. E., Rynkiewicz, S. M. & Pottinger, R. E. 1953. Does the administration of diethylstilboestrol during pregnancy have therapeutic value? American Journal of Obstetrics & Gynecology 66, 1062–1075.Google Scholar
Gambrell, R. D. 1987. Hormone replacement therapy and breast cancer. Maturitas 9, 123–133.CrossRefGoogle ScholarPubMed
Gambrell, R. D., Maier, R. C. & Sanders, B. I. 1983. Decreased incidence of breast cancer in postmenopausal oestrogen – progestogen users. Obstetrics and Gynecology 62, 435–443.Google ScholarPubMed
Greenberg, E. R., Barnes, A. B., Resseguie, L., Barrett, J. A., Burnside, A., Lanza, L. L., Neff, R. K., Stevens, M., Young, R. H. & Colton, T. 1984. Breast cancer in mothers given diethylstilboestrol in pregnancy. New England Journal of Medicine 311, 1393–1398.CrossRefGoogle ScholarPubMed
Greenberg, E. R., Resseguie, L., Barrett, J. A., Burnside, A., Lanza, L. L., Neff, R. K., Stevens, M., Young, R. H. & Colton, T. 1985. Breast cancer in mothers given diethylstilboestrol in pregnancy. New England Journal of Medicine 312, 1059–1060.Google Scholar
Henderson, B. E., Pike, M. C. & Casagrande, J. T. 1981. Breast cancer and the oestrogen window hypothesis. Lancet ii, 363–364.CrossRefGoogle Scholar
Herbst, A. L., Ulfelder, H. & Poskanzer, D. C. 1971. Adenocarcinoma of the vagina. Association of maternal stilboestrol therapy with tumour appearance in young women. New England Journal of Medicine 284, 878–881.CrossRefGoogle ScholarPubMed
Hill, A. B. 1965. The environment and disease: Association or causation. Proceedings of the Royal Society of Medicine 58, 295–300.Google Scholar
Hoel, D. G., Wakabayashi, T. & Pike, M. C. 1983. Secular trends in the distribution of breast cancer risk factors – menarche, first birth, menopause, and weight – in Hiroshima & Nagasaki, Japan. American Journal of Epidemiology 118, 78–89.Google Scholar
Hoover, R., Gray, L. A., Cole, P. & MacMahon, B. 1976. Menopausal oestrogens and breast cancer. New England Journal of Medicine 295, 401–405.CrossRefGoogle ScholarPubMed
Hoover, R., Glass, A., Finkle, W. D., Azevedo, D. & Milne, K. 1981. Conjugated oestrogens and breast cancer risk in women. Journal of the National Cancer Institute 67, 815–820.Google ScholarPubMed
Hulka, B. S., Chambless, L. E., Deubner, D. C. & Wilkinson, W. E. 1982. Breast cancer and oestrogen replacement therapy. American Journal of Obstetrics & Gynecology 143, 638–644.Google Scholar
Hunt, K., Vessey, M., McPherson, K. & Coleman, M. 1987. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. British Journal of Obstetrics & Gynecology 94, 620–635.Google Scholar
Jick, H., Walker, A. M., Watkins, R. N., D'Ewart, D. C., Hunter, J. R., Danford, A., Madsen, S., Dinan, B. J. & Rothman, K. J. 1980. Replacement oestrogens and breast cancer. American Journal of Epidemiology 112, 586–594.Google Scholar
Kalache, A. & Vessey, M. 1982. Risk factors for breast cancer. Clinics in Oncology 1, 661–678.Google Scholar
Kaufman, D. W., Miller, D. R., Rosenberg, L., Helmrich, S. P., Stolley, P., Schottenfeld, D. & Shapiro, S. 1984. Noncontraceptive oestrogen use and the risk of breast cancer. Journal of the American Medical Association 252, 63–67.CrossRefGoogle ScholarPubMed
Kelsey, J. L., Fischer, D. B., Holford, T. R., LiVolsi, V. A., Mostow, E. D., Goldenberg, I. S. & White, C. 1981. Exogenous oestrogens and other factors in the epidemiology of breast cancer. Journal of the National Cancer Institute 67, 327–333.Google ScholarPubMed
Key, T. J. A. & Pike, M. C. 1988. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. European Journal of Cancer and Clinical Oncology 24, 29–43.CrossRefGoogle ScholarPubMed
Korenman, S. G. 1980. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet i, 700–701.CrossRefGoogle Scholar
La Vecchia, C., Decarli, A., Di Pietro, S., Franceschi, S., Negri, E. & Parazzini, F. 1985. Menstrual cycle patterns and the risk of breast cancer. European Journal of Cancer and Clinical Oncology 21, 417–422.Google Scholar
La Vecchia, C., Decarli, A., Parazzini, F., Gentile, A., Liberati, C. & Franceschi, S. 1986. Non-contraceptive oestrogens and the risk of breast cancer in women. International Journal of Cancer 38, 853–858.Google Scholar
Mant, D. & Vessey, M. (in press). The epidemiology of breast cancer. In The Breast: a comprehensive textbook for the management of benign and malignant disease of the breast, eds. Bland, K. I. & Copeland, E. M., Philadelphia: W. B. Saunders.Google Scholar
McPherson, K., Coope, P. A. & Vessey, M. P. 1986. Early oral contraceptive use and breast cancer: theoretical effects of latency. Journal of Epidemiology and Community Health 40, 289–294.CrossRefGoogle ScholarPubMed
McPherson, K., Vessey, M. P., Neil, A., Doll, R., Jones, L. & Roberts, M. 1987. Early oral contraceptive use and breast cancer: Results of another case-control study. British Journal of Cancer 56, 653–660.CrossRefGoogle ScholarPubMed
Meirik, O., Lund, E., Adami, H.-O., Bergstrom, R., Christoffersen, T. & Bergsjo, P. 1986. Oral contraceptive use and breast cancer in young women. Lancet ii, 650–654.Google Scholar
Miller, D. R., Rosenberg, L., Kaufman, D. W., Scottenfeld, D., Stolley, P. D. & Shapiro, S. 1986. Breast cancer risk in relation to early oral contraceptive use. Obstetrics & Gynecology 68, 863–868.Google Scholar
Nomura, A. M. Y., Kolonel, L. N., Hirohata, T. & Lee, J. 1986. The association of replacement oestrogens with breast cancer. International Journal of Cancer 37, 49–53.CrossRefGoogle ScholarPubMed
Paul, C., Skegg, D. C. G., Spears, G. F. S. & Kaldor, J. M. 1986a. Oral contraceptives and breast cancer: a national study. British Medical Journal 293, 723–726.CrossRefGoogle ScholarPubMed
Paul, C., Skegg, D. C. G., Spears, G. F. S. & Kaldor, J. M. 1986b. The pill and breast cancer: why the uncertainty? British Medical Journal 293, 1433–1434.Google Scholar
Pike, M. C. 1985. Endogenous hormones. In Cancer Risks and Prevention, eds Vessey, M. P. & Gray, M., pp. 195–210. Oxford: Oxford University Press.Google Scholar
Pike, M. C., Henderson, B. E., Casagrande, J. T., Rosario, I. & Gray, G. E. 1981. Oral contraceptive use and early abortion as risk factors for breast cancer in young women. British Journal of Cancer 43, 72–76.CrossRefGoogle ScholarPubMed
Pike, M. C., Krailo, M. D., Duke, A. & Roy, S. 1983a. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet ii, 926–930.CrossRefGoogle Scholar
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T. & Hoel, D. G. 1983b. “Hormonal” risk factors, “breast tissue age” and the age-incidence of breast cancer. Nature 303, 767–770.Google Scholar
Ravnihar, B., Zakelj, M. P., Kosmelj, K. & Stare, J. 1988. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma 35, 109–121.Google Scholar
Rohan, T. E. & McMichael, A. J. 1988. Non-contraceptive exogenous oestrogen therapy and breast cancer. Medical Journal of Australia 148, 217–221.Google Scholar
Ross, R. K., Paganini-Hill, A., Gerkins, V. R., Mack, T. M., Pfeffer, R., Arthur, M. & Henderson, B. E. 1980. A case-control study of menopausal oestrogen therapy and breast cancer. Journal of the American Medical Association 243, 1635–1639.Google Scholar
Ross, R. K., Krailo, M., Pike, M. C. & Henderson, B. E. 1985. Breast cancer in mothers given diethylstilboestrol in pregnancy. New England Journal of Medicine 312, 1059.Google Scholar
Schlesselman, J. J., Stadel, B. V., Murray, R. & Lai, S. 1988. Breast cancer in relation to early use of oral contraceptives. Journal of the American Medical Association 259, 1828–1833.CrossRefGoogle ScholarPubMed
Sherman, B., Wallace, R. & Bean, J. 1983. Oestrogen use and breast cancer: interaction with body mass. Cancer 51, 1527–1531.3.0.CO;2-T>CrossRefGoogle ScholarPubMed
Skegg, D. C. G. 1988. Potential for bias in case-control studies of oral contraceptives and breast cancer. American Journal of Epidemiology 127, 205–212.Google Scholar
Smith, O. W. & Smith, G. van S. 1949. The influence of diethylstilboestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas. American Journal of Obstetrics & Gynecology 58, 994–1005.Google Scholar
Stadel, B. V., Rubin, G. L., Webster, L. A., Schlesselman, J. J. & Wingo, P. A. 1985. Oral contraceptives and breast cancer in young women. Lancet ii, 970–973.Google Scholar
Swyer, G. I. M. 1983. Progestagen “potency” and breast cancer. Lancet ii, 1416.Google Scholar
Thomas, D. B., Persing, J. P. & Hutchinson, W. B. 1982. Exogenous oestrogens and other risk factors for breast cancer in women with benign breast diseases. Journal of the National Cancer Institute 69, 1017–1025.Google Scholar
Vessey, M. P. 1981. Epidemiological studies of the long-term effects of birth control methods. In Recent Advances in Fertility Regulation, eds. Fen, C. C., Griffin, D. & Woolman, A., pp. 365–377. Geneva: World Health Organisation.Google Scholar
Vessey, M. P. 1988. Oral contraception and cancer. In Contraception – Science and Practice, eds. Filshie, M. & Guillebaud, J., pp. 52–68. Guildford: Butterworth.Google Scholar
Vessey, M. P., McPherson, K., Yeates, D. & Doll, R. 1982. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk. British Journal of Cancer 45, 327–331.CrossRefGoogle ScholarPubMed
Vessey, M. P., Fairweather, D. V. I., Norman-Smith, B. & Buckley, J. 1983. A randomized double–blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. British Journal of Obstetrics & Gynecology 90, 1007–1017.Google Scholar
Wingo, P. A., Layde, P. M., Lee, C. C., Rubin, G. & Ory, H. W. 1987. The risk of breast cancer in postmenopausal women who have used oestrogen replacement therapy. Journal of the American Medical Association 257, 209–215.Google Scholar
Wynder, E. L. & Schneiderman, M. A. 1973. Exogenous hormones – boon or culprit. Journal of the National Cancer Institute 51, 729–731.Google Scholar